Updates to FIT Guidance
In August 2023 NICE published updated guidance on ‘Quantitative faecal immunochemical testing (FIT)’ to guide colorectal cancer pathway referral in primary care. This update expands and clarifies the previous recommendations, based on the extensive clinical evidence that has accumulated since DG30 was originally published, back in July 2017.
What are the main changes?
What does this mean for FIT?
How does Alpha Laboratories support NICE DG56?
Read our article from our latest issue of Leading Edge to find out.
